Phenobarbital IV to Oral Conversion Ratio
Yes, the dosing for phenobarbital intravenous (IV) to oral administration is 1:1 (100% bioavailability), meaning the same dose can be used when converting between these routes. 1, 2
Evidence for 1:1 Conversion
- Studies have demonstrated that phenobarbital has complete bioavailability (approximately 100%) when administered orally compared to intravenous administration 2
- Research shows that phenobarbital's pharmacokinetic properties remain consistent across different routes of administration, allowing for equivalent dosing between IV and oral routes 2
- In a study of epileptic patients and normal subjects, the absolute bioavailability of phenobarbital was found to be essentially complete, supporting a 1:1 conversion ratio 2
Pharmacokinetic Considerations
- Phenobarbital is primarily metabolized in the liver by CYP2C9 with minor metabolism by CYP2C19 and CYP2E1 3
- Approximately 25% of the phenobarbital dose is excreted unchanged in the urine 3
- The half-life of phenobarbital is approximately:
Clinical Application
- When converting from IV to oral phenobarbital:
- For status epilepticus treatment:
Route-Specific Considerations
- Oral administration may have slightly variable absorption timing compared to IV:
- Rectal administration has also been shown to be reliable with good bioavailability, making it a viable alternative when oral or IV routes are not available 1
Common Pitfalls to Avoid
- Do not confuse phenobarbital with other barbiturates that may have different bioavailability profiles 5
- Remember that while the dose remains the same, the onset of action will be delayed with oral administration compared to IV 2
- Monitor for therapeutic levels regardless of administration route, with therapeutic serum concentrations typically up to 40 μg/ml 3
- Be aware that patients with refractory seizures may require higher serum concentrations (up to 100 μg/ml) 3